One Health News

Search News:
Found 38 Matching Results. View archived News Here.

June 8, 2018—American Public Health Association (APHA) Organizations’ letter to U.S. Congress Appropriations Committee leaders in support of strong investments in antimicrobial resistance in FY 2019 appropriations bills using ONE HEALTH APPROACH - Saturday, July 07, 2018

June 8, 2018—American Public Health Association (APHA) Organizations’ letter to U.S. Congress Appropriations Committee leaders in support of strong investments in antimicrobial resistance in FY 2019 appropriations bills using ONE HEALTH APPROACH


3rd paragraph,

“The report also highlights the need for continued and robust funding for AMR given that nationwide testing last year documented 221 cases of so-called “nightmare bacteria,” that can spread resistance to last-resort antibiotics. Robust, sustained investment in multi-agency One Health efforts is vital to combat AMR domestically and globally including prevention, antimicrobial stewardship, surveillance and data collection, research, and development of urgently needed new products including antimicrobial drugs, diagnostics, vaccines and alternative treatments.”


11th paragraph,

“Food and Drug Administration and US Department of Agriculture Experts agree that a One Health approach, including both human and animal health, is essential for combating antimicrobial resistance. We urge funding of $54 million for the Combating Antibiotic Resistant Bacteria initiative at FDA to support FDA’s efforts to address public health concerns associated with antimicrobial drug use in animals, and better protect antibiotic effectiveness for both human and animal populations. This funding is needed now more than ever, with estimates that antibiotic use in humans and livestock will rise by 50% before 2030. FDA would be able to better collaborate with consumers, producers, veterinarians, and other agencies to monitor AMR through the National Antimicrobial Resistance Monitoring System (NARMS) as well as other initiatives by the FDA Center for Veterinary Medicine to address AMR.”

Notably, see list of prominent organizational signatories:

Accelerate Diagnostics, Inc.


Alliance for Aging Research

Alliance for the Prudent Use of Antibiotics

American Academy of Pediatrics

American Association of Avian Pathologists

American Association of Bovine Practitioners

American Public Health Association

American Society of Transplant Surgeons

American Society of Tropical Medicine & Hygiene

American Thoracic Society

American Veterinary Medical Association

Antibiotic Resistance Action Center, the George Washington University

Antimicrobials Working Group (Amplyx Pharmaceuticals, Aridis Pharmaceuticals, Arsanis Inc., Cidara Therapeutics Inc., ContraFect Corporation, Iterum Therapeutics Ltd., Melinta Therapeutics Inc., Motif Bio plc, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., SCYNEXIS Inc., Spero Therapeutics, Inc., T2 Biosystems Inc., Theravance Biopharma U.S. Inc., Viamet, Vical Incorporated, and Zavante Therapeutics Inc.)

Association for Professionals in Infection Control and Epidemiology

Association of American Veterinary Medical Colleges

Association of State and Territorial Health Officials

Becton Dickinson and Co. (BD)


Biotechnology Innovation Organization (BIO)

Center for Disease Dynamics, Economics & Policy

Center for Foodborne Illness Research and Prevention

Clinician Champions in Comprehensive Antibiotic Stewardship

Consumer Federation of America

Council of State and Territorial Epidemiologists

Da Volterra

Duke Center for Antimicrobial Stewardship and Infection Prevention

Emory Antibiotic Resistance Center

Food Animal Concerns Trust


Global Health Council

Health Care Without Harm

HIV Medicine Association

Immune Deficiency Foundation

Infectious Diseases Society of America

Johns Hopkins Center for a Livable Future

Making-A-Difference in Infectious Diseases

March of Dimes

National Association of County and City Health Officials

National Association of Pediatric Nurse Practitioners

NovaDigm Therapeutics, Inc.

Pediatric Infectious Diseases Society

Peggy Lillis Foundation

Sepsis Alliance

Society of Critical Care Medicine

Society of Infectious Diseases Pharmacists

Spero Therapeutics

The Fecal Transplant Foundation

The Gerontological Society of America

The Pew Charitable Trusts

The Society for Healthcare Epidemiology of America

The Society of Critical Care Medicine

Treatment Action Group

Trust for America's Health

This “Advancing Emergency Preparedness Through One Health Act of 2018 (S.2615)” One Pager - Call to Action was prepared by a voluntary ad hoc committee of representative One Health advocate-leaders... - Wednesday, April 18, 2018

One Health is the collaborative efforts of multiple disciplines working locally, nationally, and globally to attain optimal health for people, animals, plants and our environment.

One Health implementation will help protect and/or save untold millions of lives in our generation and for those to come.

 Between animal and human medicine there are no dividing lines--nor should there be.  The object is different but the experience obtained constitutes the basis of all medicine.”

  --Rudolf Virchow, MD (the father of cellular pathology)--

This “Advancing Emergency Preparedness Through One Health Act of 2018 (S.2615)” One Pager - Call to Action was prepared by a voluntary ad hoc committee of representative One Health advocate-leaders...

Please see complete draft PDF or

Committee members:

Joseph F. Annelli, DVM, MS - Former Director, One Health Coordination Center, Senior Advisor for Agriculture and Health Systems, Office of the Associate Deputy Administrator, Veterinary Services, Animal and Plant Health Inspection Service (APHIS), United States Department of Agriculture (USDA) – Principal Author

Helena J. Chapman, MD, MPH, PhD – Currently, American Association for the Advancement of Science (AAAS) fellowship, National Aeronautics and Space Administration (NASA) Earth Science Division, Washington, DC  

Bernadette Dunham, DVM, PhD - Former Director, Center for Veterinary Medicine, U.S. Food and Drug Administration, Rockville, MD. Currently, Professorial Lecturer, The Milken Institute School of Public Health, George Washington University, Washington, DC – Committee Legislation Leader & Primary Spokesperson

Bruce Kaplan, DVM - Contents Manager/Editor One Health Initiative website, co-founder One Health Initiative Autonomous pro bono Team (OHI), former U.S. Centers for Disease Control & Prevention (CDC) epidemiologist (EIS) and USDA Food Safety and Inspection Service (FSIS) staff officer, Office of Public Health and Science (OPHS), Washington, DC

Carrie La Jeunesse, DVM, CT - Owner and Principal LaJeune Consulting; Alumna American Association for the Advancement of Science (AAAS) Congressional Sciences & Technology Policy Fellow, U.S. House of Representatives; past President Washington State Veterinary Medical Association

Gerald W. Parker, DVM, PhD, MS - Currently, Associate Dean for Global One Health, Texas A&M University College of Veterinary Medicine & Biomedical Sciences (CVM), serving as Campus Director for Global One Health for Texas A&M University, holding joint appointments in the College of Agriculture & Life Sciences, as strategic advisor of the Institute for Infectious Animal Diseases in AgriLife Research, and the Bush School of Government & Public Service, as Director of the Biosecurity and Pandemic Policy Program.  Formerly principal deputy assistant secretary  U.S. Department of Health and Human Services’ (DHHS) Office of the Assistant Secretary for Preparedness and Response.

Cheryl M. Stroud, DVM, PhD - Executive Director, One Health Commission (OHC), former American Veterinary Medical Association (AVMA) representative to OHC, Immediate Past Chair, North Carolina One Health Collaborative (NC OHC), Adjunct Assistant Professor, Department of Clinical Sciences, NC State University, College of Veterinary Medicine

The One Health Commission (OHC) and One Health Initiative Autonomous pro bono Team (OHI) mutually encourage all One Health community supporters to help widely distribute, promote and actively participate in this call to action for significant bipartisan One Health/public health legislation consideration and expeditious enactment by the U.S. Congress.  Notably, “One Health” is a nonpartisan issue.


One Health Lecture - April 11, 2018-- The Oncopig Cancer Model (OCM):A PLatform for Transitional, Translational and Transformative Advances in Cancer Research - Monday, March 19, 2018


One Health Lecture

The Oncopig Cancer Model (OCM): A Platform for Transitional, Translational and Transformative Advances in Cancer Research


 Wednesday, April 11
5:30 pm
College of Veterinary Medicine
Room 2226 Vet Med
Recorded link pending
Livestream link

Presented by Dr. Lawrence B. Schook,

Lawrence B. Schook, PhD, Edward William and Jane Marr Gutsgell Professor of Animal Sciences and Radiology, previously served as the Vice President for Research at the University of Illinois, overseeing the technology commercialization and economic development activities across the University’s three campuses (Urbana-Champaign, Chicago, Springfield). Previously, he served as founding Director, UIUC Division of Biomedical Sciences and the founding Woese Institute for Genomic Biology (IGB) Theme Leader for Regenerative Biology and Tissue Engineering. Dr. Schook is a recognized international scholar in comparative genomics and is known for leading the pig genome-sequencing project, which has provided researchers insights into human cancer and other chronic diseases. He is a noted entrepreneur who has launched three health startup companies. Schook is currently funded by the NIH and the DOD to develop the pig as a biomedical cancer model and has been the PI in extramural funding from the NIH, NSF and USDA. He has co-authored/edited nine books and over 250 publications, has trained 43 graduate students, mentored 35 undergraduate projects and 25 postgraduate scholars. He has appointments in bioengineering, nutritional sciences, veterinary pathobiology, pathology, surgery, the Institute for Genomic Biology and the Beckman Institute. He was a Fellow at the Academy for Entrepreneurial Leadership and the National Center for Supercomputer Applications. Dr. Schook is a founding director of UI LABS, a Chicago-based research and commercialization collaborative that spun out of the University. A Fellow of the American Association for the Advancement of Science, he currently serves on the Board of Trustees for Albion College, and the boards of the National Academy of Sciences Institute for Laboratory Animal Science Council, Translational Research and Innovative Oncology, Inc., Onclavus, Inc., and the Illinois Technology Association Internet of Things Council. He previously served on the Board of Managers for the Fermi and Argonne National Laboratories, and Illinois Governor Quinn’s Innovation Council. Dr. Schook obtained Postdoctoral Fellowships from the Institute of Clinical Immunology, University of Berne, Switzerland and University of Michigan School of Medicine, Ann Arbor; Ph.D. from the Wayne State School of Medicine, Detroit, Michigan; and B.A. from Albion College, Michigan.

The One Health Lecture Series was established in the College of Veterinary Medicine at Iowa State University in honor of Dr. Roger Mahr, DVM Class of 1971

Provided March 19, 2018 by:

Claire B. Andreasen DVM, PhD, Diplomate ACVP

Professor, Department of Veterinary Pathology

Director of One Health

College of Veterinary Medicine

Iowa State University


Dr. Andreasen is a longstanding One Health Supporter/Advocate

One health: Joint health research - Wednesday, February 28, 2018

EurekAlert! Science News

A service of the American Association for the Advancement of Science

Public Release: 28-Feb-2018

One health: Joint health research

BfR, FLI and RKI support the European program for the reduction of infectious diseases in humans and animals

BfR Federal Institute for Risk Assessment


 Print  E-Mail

"Antimicrobial resistance and threats through new pathogens are controversial examples of the extent to which the health and illness of humans, animals and the environment are linked together," says Professor Dr. Dr. Andreas Hensel, President of the German Federal Institute for Risk Assessment (BfR). "A joint European research programme under the auspices of One Health can help to counter microbial risks effectively." The German partners of the European Joint Programme on One Health are the BfR, the Friedrich Loeffler Institute and the Robert Koch Institute.

The goal of the European Joint Programme (EJP) is to build up a European platform for One Health which satisfies the needs of European and national political decision makers and interest groups (stakeholders). To this end, European institutions from the fields of medicine, veterinary medicine and consumer health protection in the food sector are to expand their cooperation in order to achieve progress in the containment of foodborne zoonoses (infections transferred between humans and animals), antimicrobial resistance and new infection hazards (emerging threats).

The One Health concept takes into account the close link between human health, animal health and the environment. Accordingly, the close connection between the safety of feeds and foods and human and animal health and environmental contamination is observed. The examination of infectious pathogens which can be transferred from animals to humans is an important focal point of this EJP, a new research programme within the EU framework programme for research and innovation "Horizon 2020" sponsored by the European Commission. The One Health EJP (Grant Agreement 773830) is headed by the French Agency for Food, Environmental and Occupational Health and Safety (ANSES).

The cooperation between the 40 partners is to be strengthened by the programme. Each partner also has reference tasks, which means that they set the yardstick for examinations. They already form an organised network and represent a research community in the thematic areas of foodborne zoonoses, antimicrobial resistance and emerging threats. Over a total period of five years, a sum of € 90 million is to be spent on activities within this network. 50% of the costs are being provided by the European Commission with the other half being carried by each respective member state.

The One Health EJP will generate scientific data, methods and software programs which can be used by national and European institutions to assess health risks and possible preventive measures. An exchange with other large-scale projects sponsored by the European Commission will be guaranteed at the same time. One of the tasks will be the efficient and regular transfer of knowledge between the research community and national authorities, as well as international and European stakeholders.

BfR sub-projects

A further goal of the One Health EJP is the expansion of collaboration between the institutes through interdisciplinary cooperation. This is to be realised through joint research projects and integrative schemes, as well as basic and further training measures. The BfR is involved in five research projects and two integrative schemes and is heading the "Science to Policy Translation" work package, in which measures for the best possible transfer of results from the research projects and integrative schemes to the stakeholders involved in the areas of foodborne zoonoses, antimicrobial resistance and emerging threats are to be developed.

The BfR is also coordinating the integrative project "ORION" (One health surRveillance Initiative on harmOnisation of data collection and interpretation). The main focus of this project is the exchange of data and information generated during the monitoring, collection and interpretation of data on health and wellbeing. Cooperation among the institutions is also being further improved through the cooperation of 13 institutes from seven countries active in the fields of public health and veterinary medicine.


About the BfR

The German Federal Institute for Risk Assessment (BfR) is a scientifically independent institution within the portfolio of the Federal Ministry of Food and Agriculture (BMEL) in Germany. It advises the Federal Government and Federal Laender on questions of food, chemical and product safety. The BfR conducts its own research on topics that are closely linked to its assessment tasks.

This text version is a translation of the original German text which is the only legally binding version.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.


Ten Years of Important documented One Health highlights...still valid today: ONLY Tip-of-the-Iceberg! - Tuesday, January 09, 2018

Why One Health? 

Ten years of Important documented One Health highlights...still valid today: ONLY Tip-of-the-Iceberg!

Editor’s note: By definition, “In a jury trial, a directed verdict is an order from the presiding judge to the jury to return a particular verdict. Typically, the judge orders a directed verdict after finding that no reasonable jury could reach a decision to the contrary.” 

The following, in addition to other documented examples [and many others in numerous publications], including endorsements of One Health/One Health Approach by a large cadre of reputable national and international individuals, organizations and institutions &, would likely lead most, if not all, presiding judges to issue a directed verdict in favor of One Health/One Health Approach implementation forthwith!


September 2017:

MOST RECENT, SEE Renowned Physician Interventional Cardiologist Endorses One Health Concept


August 2016: Former director, Center for Veterinary Medicine, U.S. Food and Drug Administration, speaks at Library of Congress discussing (about 56 minutes) interconnections of human and animal health with environmental health.   Pointed out was that no one discipline or sector of society has enough knowledge and resources to prevent the emergence or resurgence of diseases in today's globalized world. This "One Health" concept is a worldwide strategy for expanding interdisciplinary collaborations and communications in all aspects of health care for humans, animals, and the environment


October 2015: Hudson Institute Report NATIONAL BLUEPRINT FOR BIODEFENSE:

Report in full:

TABLE 1: RECOMMENDATIONS AND ACTION ITEMS Integrate animal health and One Health approaches into biodefense strategies.

Recommendation 7a Institutionalize One Health. ... III. RECOGNIZING AND INSTITUTIONALIZING THE ONE HEALTH CONCEPT See pages 19 & 20

“...A One Health approach can also inform priorities for human infectious diseases. When it became clear in 2014 that no countermeasures for Ebola were ready for the largest Ebola outbreak the world had ever seen, many policy conversations that followed were about priorities. We must have a means of determining what to fund with finite resources. The threats and risks among agents of both bioterror and emerging infectious diseases are equally serious. MTDs have been very important for the prioritization of activities around biodefense, yet there is no analogous prioritization system for emerging diseases....”


December 2014: “The business case for One Health” - Onderstepoort Journal of Veterinary Research 81(2), 6 pages – Open Access


September 2013: Visionary landmark article Vaccines against diseases transmitted from animals to humans: A one health paradigm” by medical virologist and vaccinologist physician notes principles of utilizing the One Health approach, i.e. multidisciplinary/interdisciplinary collaborations between animal health and human health industries and regulators can definitely help develop immunization products for such purposes.  gives reasonable guidelines to make it happen sooner rather than later. Examples: including West Nile, brucellosis, Escherichia coli, O157:H7, rabies, Rift Valley fever, Venezuelan equine encephalitis, Hendra virus, Mycobacterium bovis, and Lyme disease. Indeed, another September 2013 publication was published that discussed the dramatic food safety potential for using a vaccine in cattle to protect against human foodborne illness caused by E. coli, O157


November 2012: American Association of Public Health Physicians (AAPHP) President Endorses One Health and


November 2011: National League of Cities - Adopted [One Health Resolution] at the 2011 Congress of Cities


January 2010: ILAR Journal, 2010, Volume 51 Number 3, “One Health: The Intersection of Humans, Animals, and the Environment”: ;


June 2009: Orthopedic Surgeons (a veterinarian and physician) Research Creative Hip and Knee replacements for Dogs and Humans Together -

One Health in ACTION!  Orthopedic Surgeons (a veterinarian and physician) Research Creative Hip and Knee Replacements for Dogs and Humans Together


March 2008: Classic relevant One Health PowerPoint slides at ICEID meeting in Atlanta, GA...from a co-founder One Health Initiative team & website, an eminent virologist and vaccinologist

Editor’s addendum:  Please see

One health researchers identify hot spots of tick-borne diseases in Mongolia - George Mason University (USA) - Thursday, November 16, 2017

A service of the American Association for the Advancement of Science

EurekAlert! Science NewsA service of the American Association for the Advancement of Science

Public Release: 16-Nov-2017

One health researchers identify hot spots of tick-borne diseases in Mongolia

George Mason University (USA)

Given the critical role livestock play in Mongolia, transmission of tick-borne diseases can have very real health and economic implications for livestock and the herders that tend to them. Dr. Michael von Fricken explored this association using a multidisciplinary One Health research approach, which focused on the interaction between nomadic herders, the livestock they own, and the tick-borne diseases they are exposed to. von Fricken spent a year living in Ulaanbataar as a postdoc with Duke University, under Dr. Greg Gray, working alongside veterinarians from the Institute of Veterinary Medicine and the National Center for Zoonotic Diseases.

Read complete article:

Note: Dr. Gray is an extraordinary physician One Health leader and member of the One Health Initiative Hon. Advisory Board

UC Davis (USA) Commentary on G-20 Nations recommend adopting One Health Approach for Antimicrobial Resistance (AMR) - Wednesday, July 12, 2017

Michael Lairmore, Dean, Veterinary Medicine

Dean's Musings

Addressing Societal Needs by Combating Antimicrobial Resistance

By Michael Lairmore On July 11, 2017

 “Infectious disease exists at this intersection between real science, medicine, public health, social policy, and human conflict.” – Andrea Barrett

As part of our school’s vision, we seek to address societal needs. In challenging ourselves to this daunting task of working to solve the most vexing problems our world faces, we find our people and programs drawn toward the interface of science, public health, and policy. In opening remarks at the recent G20 Conference, Angel Gurría, Secretary-General of the Organization for Economic Co-operation and Development, praised Germany Chancellor Angela Merkel for recognizing that antimicrobial resistance (AMR) is a major threat to the health of the world’s populations and the future of economies of the many countries.

He indicated that as many as 700,000 people worldwide are already dying each year because of drug-resistant infections and that the cumulative economic cost of AMR will reach 100 trillion dollars by 2050, a cost primarily borne by low and middle income countries. The Secretary-General went on to suggest that “by implementing existing international commitments and recommendations of the World Health Organization, Food and Agriculture Organization of the United Nations and World Organization for Animal Health, countries can promote a more appropriate use of antimicrobials in a true ‘One Health’ framework.”

Antimicrobial resistance is an example of a major societal issue that our school has been making significant efforts to understand and combat. These efforts include forming partnerships with state and national organizations to inform stakeholders on a new Food and Drug Administration Guidance on the use of antimicrobials, to working with the California Veterinary Medical Association and the California Department of Food and Agriculture to develop evidence-based science policies in California to ensure the proper use of antimicrobials to advance animal health, while not overusing important human drugs for growth promotion as feed additives.

Dr. Terry Lehenbauer, director of the UC Davis Veterinary Medical Teaching and Research Center in Tulare, participated in a recent American Public and Land-grant University/American Association of Veterinary Medical Colleges Working Group to develop antimicrobial resistance curriculum learning outcomes, which were featured at a U.S. Capitol Hill Briefing. We have successfully competed for a new cooperative extension specialist faculty position focused on antimicrobial resistance research and outreach. This new faculty member will join a comprehensive group of faculty members who are studying AMR from multiple vantage points to address this important health threat.

The California Animal Health & Food Safety Laboratory (CAHFS) in Tulare, a diagnostic laboratory devoted to protecting farm animals, the food supply and the public against new and emerging diseases. The Tulare facility is one of four labs in the California Animal Health and Food Safety Laboratory System, headquartered at UC Davis and operated for the state by the veterinary school to protect animal health and performance, and safeguard public health and the food supply.

Our California Animal Health and Food Safety laboratory diagnosticians and scientist are actively seeking ways to monitor drug-resistant bacteria in our food supply. Our scientists are using the latest technologies to genetically analyze food-borne pathogens, especially those that may be resistant to commonly used antibiotics. Our school has partnered with the Farm Foundation to bring together the state’s livestock and poultry producers, their feed suppliers and veterinarians to discuss the changing landscape of antibiotic drug use in food animals. Knowledge related to the proper use of antibiotics is then offered to our stakeholders throughout the State of California via our cooperative extension faculty through conferences, proceedings, and other public outreach efforts.

Collectively, our people and programs are on the front lines of counteracting AMR, exemplifying our vision to address this pressing societal need. In doing so, we are in lock-step with other G20 countries committed to promoting the appropriate use of antimicrobials through a One Health approach.

Please see link for full article:

Provided by: 

Michael D. Lairmore DVM, PhD

Dean and Distinguished Professor

School of Veterinary Medicine

University of California – Davis

One Shields Avenue

Davis, CA 95616

Tel (530) 752-1361

Fax (530) 752-2801


Twitter: @LairmoreDVMDean

Note:  Dr. Lairmore is a longstanding One Health leader and champion


Two notable public health (USA) ‘One Health’ advocate organizations - Friday, February 03, 2017

Two notable public health (USA) ‘One Health’ advocate organizations:


American Association of Public Health Physicians (AAPHP)



American Veterinary Epidemiology Society (AVES)

One Health and the Politics of Antimicrobial Resistance – September 13, 2016 (Tomorrow) – Washington, DC - Monday, September 12, 2016

One Health and the Politics of Antimicrobial Resistance – September 13, 2016 (Tomorrow) – Washington, DC

American Association for Advancement of Science (AAAS) -  

Dr. Laura H. Kahn [MD, MPH, MPP] will discuss her recently published book, “One Health and the Politics of Antimicrobial Resistance”, in which she analyzes the surprising outcomes of differing policy approaches to antibiotic resistance around the globe. Integrating the perspectives of both medicine and agriculture and exploring the history and science behind the widespread use of growth-promoting antibiotics, Dr. Kahn examines the controversy in a unique way while offering policy recommendations that all sides can accept. ...”

See more at

Note: Dr. Kahn is co-founder of the One Health Initiative team and One Health Initiative website

INTERNATIONAL FEDERATION ON AGEING (IFA) Recognizes Health Value of “Human-animal bond”, a One Health Umbrella* Inclusion - Saturday, July 30, 2016

INTERNATIONAL FEDERATION ON AGEING (IFA) Recognizes Health Value of “Human-animal bond”, a One Health Umbrella* Inclusion  

Companion Animals and the Health of Older Persons: International Day of Friendship

July 30th is the International Day of Friendship, which was first proclaimed in 2011 by the UN General Assembly. The goal of the International Day of Friendship is to build bridges between communities by encouraging friendship and peace efforts between people, cultures, countries and individuals.

The relationship between people and companion animals has a long standing history, and has been documented throughout different cultures around the world. The “human-animal bond” is a mutually beneficial, dynamic relationship between people and animals, that has proven benefits for emotional, social, physical and psychological health. The concept of “One Health” is important to consider when discussing this relationship, and is defined by the One Health Initiative as:

“One Health is the collaborative efforts of multiple disciplines working locally, nationally, and globally to attain optimal health for people, animals, plants and our environment.” – One Health Initiative

As part of the Companion Animals & the Health of Older Persons Infographic Series, the IFA and Bayer Animal Health, along with several other partner organizations including One Health Initiative, American Association of Human-Animal Bond Veterinarians (AAH-ABV), Animal & Societies Institute, Federation of European Companion Animal Veterinary Associations (FECAVA) and The World Small Animal Veterinary Association (WSAVA) created this infographic to generate awareness about the importance of the human-animal bond. ...MORE BELOW:

and also see…

One Health Initiative
Home | About One Health | Mission Statement | One Health News | AVMA Task Force Report | One Health Newsletter |
Publications | Supporters | Supporter Endorsements | Upcoming Events | Contact Us